JEFFREY YORDON - 20 Jul 2022 Form 4 Insider Report for Athenex, Inc. (ATNX)

Role
COO, and President, Athenex Pharmaceutical Division. Exhibit List: Exhibit 24.1 - Power of Attorney
Signature
/s/Staci Holquist, Attorney-in-Fact
Issuer symbol
ATNX
Transactions as of
20 Jul 2022
Transactions value $
$0
Form type
4
Filing time
21 Jul 2022, 17:40:39 UTC
Previous filing
05 Aug 2021
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNX Common Stock 237K 20 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNX Stock Option (Right to Buy) Award $0 +150K $0.00 150K 20 Jul 2022 Common Stock 150K $0.67 Direct F6
holding ATNX Stock Option (Right to Buy) 150K 20 Jul 2022 Common Stock 150K $9.00 Direct
holding ATNX Stock Option (Right to Buy) 212K 20 Jul 2022 Common Stock 212K $11.00 Direct
holding ATNX Stock Option (Right to Buy) 100K 20 Jul 2022 Common Stock 100K $17.30 Direct
holding ATNX Stock Option (Right to Buy) 100K 20 Jul 2022 Common Stock 100K $13.17 Direct F1
holding ATNX Stock Option (Right to Buy) 100K 20 Jul 2022 Common Stock 100K $12.45 Direct F2
holding ATNX Stock Option (Right to Buy) 50K 20 Jul 2022 Common Stock 50K $3.80 Direct F3
holding ATNX Restricted Stock Units 50K 20 Jul 2022 Common Stock 50K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in four equal annual installments beginning on February 28, 2020.
F2 This option vests in four equal annual installments beginning on June 5, 2021.
F3 This option vests in four equal annual installments beginning on August 3, 2022.
F4 Each restricted stock unit represents a contingent right to receive one share of stock.
F5 The restricted stock units vest in four equal annual installments beginning on August 3, 2022.
F6 This option vests in four equal annual installments beginning on July 20, 2023.

Remarks:

COO, and President, Athenex Pharmaceutical Division. Exhibit List: Exhibit 24.1 - Power of Attorney